NKGen Biotech, Inc. (NASDAQ:NKGNW) Sees Large Increase in Short Interest

NKGen Biotech, Inc. (NASDAQ:NKGNW) was the target of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 15,400 shares, an increase of 805.9% from the December 15th total of 1,700 shares. Based on an average daily volume of 14,400 shares, the days-to-cover ratio is presently 1.1 days.

NKGen Biotech Stock Performance

NKGNW stock traded up $0.00 during midday trading on Monday, reaching $0.11. 7,800 shares of the company’s stock traded hands, compared to its average volume of 10,700. The firm’s fifty day moving average price is $0.07 and its 200-day moving average price is $0.07. NKGen Biotech has a 52 week low of $0.02 and a 52 week high of $0.29.

About NKGen Biotech

NKGen Biotech, Inc operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials.